Peter Nelson
Impact in
- Cancer Research top 0.02%
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.01%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 269
- Prostate Cancer Diagnosis and Treatment 64
-
- Cancer, Lipids, and Metabolism 49
- Cancer Genomics and Diagnostics 32
- Co-authors
- Robert L. Vessella (53 shared papers)Elahe A. Mostaghel (53 shared papers)Ilsa Coleman (105 shared papers)Robert Bruce Montgomery (68 shared papers)Lawrence True (72 shared papers)Daniel Wei Lin (52 shared papers)Beatrice S. Knudsen (12 shared papers)Stephen R. Plymate (32 shared papers)
- Journals
- The Prostate (34 papers)Clinical Cancer Research (33 papers)Cancer Research (30 papers)Journal of Clinical Investigation (17 papers)PLoS ONE (15 papers)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Peter Nelson
487 papers receiving 53.2k citations
Peter Nelson's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 15.3k
- Pulmonary and Respiratory Medicine 24.0k
- Oncology 9.6k
- Molecular Biology 22.1k
- Endocrinology, Diabetes and Metabolism 3.8k
Countries citing papers authored by Peter Nelson
This map shows the geographic impact of Peter Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Nelson more than expected).
Fields of papers citing papers by Peter Nelson
This network shows the impact of papers produced by Peter Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Nelson. The network helps show where Peter Nelson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 503 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circulating microRNAs as stable blood-based markers for cancer detection Hit paper breakdown → | 2008 | 6956 |
| 2 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 2985 |
| 3 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 4 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer Hit paper breakdown → | 2016 | 1335 |
| 5 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 Hit paper breakdown → | 2016 | 1297 |
| 6 | Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth Hit paper breakdown → | 2008 | 1171 |
| 7 | Genomic correlates of clinical outcome in advanced prostate cancer Hit paper breakdown → | 2019 | 1036 |
| 8 | MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation Hit paper breakdown → | 2015 | 956 |
| 9 | Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Hit paper breakdown → | 2003 | 909 |
| 10 | Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion Hit paper breakdown → | 2009 | 714 |
| 11 | Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B Hit paper breakdown → | 2012 | 670 |
| 12 | The long tail of oncogenic drivers in prostate cancer Hit paper breakdown → | 2018 | 649 |
| 13 | Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant Hit paper breakdown → | 2010 | 619 |
| 14 | Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer Hit paper breakdown → | 2016 | 603 |
| 15 | Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling Hit paper breakdown → | 2017 | 562 |
| 16 | Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2012 | 502 |
| 17 | Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants Hit paper breakdown → | 2011 | 494 |
| 18 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer Hit paper breakdown → | 2018 | 485 |
| 19 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 461 |
| 20 | Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. | 1999 | 445 |
About Peter Nelson
Peter Nelson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 503 papers that have together received 54.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (269 papers), Prostate Cancer Diagnosis and Treatment (64 papers), Cancer, Lipids, and Metabolism (49 papers), Hormonal and reproductive studies (34 papers), Cancer Genomics and Diagnostics (32 papers), Molecular Biology Techniques and Applications (28 papers), Estrogen and related hormone effects (24 papers) and Ubiquitin and proteasome pathways (23 papers). The work is most often cited by research in Cancer Research (15.3k citations), Pulmonary and Respiratory Medicine (24.0k citations), Oncology (9.6k citations), Molecular Biology (22.1k citations) and Endocrinology, Diabetes and Metabolism (3.8k citations). Peter Nelson has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Robert L. Vessella, Elahe A. Mostaghel, Ilsa Coleman, Robert Bruce Montgomery, Lawrence True, Daniel Wei Lin, Beatrice S. Knudsen, Stephen R. Plymate, Muneesh Tewari and Daniel B. Martin. Their work appears in journals such as The Prostate, Clinical Cancer Research, Cancer Research, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.